Viewing nowCombinationExpera Tablet 5/160 milligrams
Amlodipine Besylate 6.935mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.

MFDS item code 201308502 · Approved 2013.07.30 · Insurance code 698502460
Treatment of essential hypertension not adequately controlled with monotherapy
Essential hypertension is a condition that can impose a burden on the cardiovascular system; hence, when blood pressure is not adequately controlled with monotherapy using amlodipine or valsartan, alternative treatment strategies may be necessary. This medication effectively lowers blood pressure, alleviating the burden on the heart and blood vessels, and helps reduce the risk of complications related to hypertension. These are utilized when blood pressure management is difficult with monotherapy.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Exercise caution when increasing the dose.
Pediatric patients under 18 years of age: Administration of this drug is not recommended because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second or third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals with allergies to the active ingredients of this medication or similar drugs, pregnant or potentially pregnant women, breastfeeding individuals, and those with severe kidney or liver disease should not take this medication. Patients with insufficient sodium or fluid in the body should manage their condition well before taking this medication, and if symptoms of hypotension occur during use, appropriate actions should be taken immediately. Patients with elevated blood potassium levels should be cautious when taking this medication with drugs that can increase potassium levels, and should regularly monitor blood potassium concentrations. Patients with issues related to the renal arteries or who have received kidney transplants should use this medication carefully as it may affect kidney function. During treatment with this medication, if symptoms of angioedema, such as swelling of the face, lips, or tongue occur, the use should be stopped immediately and a healthcare provider should be consulted. Patients with heart failure or post-myocardial infarction should be closely monitored for changes in kidney function while taking this medication, and careful dosing is required for patients with acute myocardial infarction. This medication may interact when used in conjunction with other blood pressure medications, so be sure to inform your healthcare provider of any other medications you are taking. Be cautious during activities such as driving or operating machinery, as dizziness or fatigue may occur. In case of overdose, symptoms such as hypotension or arrhythmia may occur, so it is important to adhere to the prescribed dosage and notify a healthcare provider immediately if there are abnormal symptoms. This medication is not recommended for individuals under 18 years of age, as its safety and efficacy have not been established for this age group. For the elderly, the dosage can be administered similarly to that of adults, but careful observation during treatment is necessary.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, xerostomia, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, reduced libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disorder, peripheral neuropathy, muscle hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitation, sensory impairment, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees.
Dark yellow oval film-coated tablet
For domestic use - 30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.935mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.